• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Mental Health Distress Impacting Cancer Patients, Says New Cardinal Health Survey of Oncologists

Article

More than 80% of oncologists frequently see mental health distress in their patients with cancer, and more than 90% say it has a significant impact on their health outcomes.

DUBLIN, Ohio, December 9, 2021 — More than 80% of oncologists frequently see mental health distress in their patients with cancer, and more than 90% say it has a significant impact on their health outcomes. These findings were released today in the latest edition of Oncology Insights, a report published by Cardinal Health Specialty Solutions based on surveys with more than 240 US oncologists.

Anxiety disorders and depression were cited by more than 80% of oncologists as the types of mental health distress seen most frequently in their patients, but personality and addiction disorders were also mentioned. Despite the high prevalence of mental health concerns, only a third of the surveyed oncologists said they frequently refer patients for mental health treatment and nearly half say there are not adequate resources available to support the mental health needs of cancer patients.

"Recent research indicates that mental health generally has declined since the start of the COVID-19 pandemic. This is particularly concerning for patients with cancer who are already at an increased risk for mental health distress," said Heidi Hunter, president of Cardinal Health Specialty Solutions. "Our latest oncology survey shines a light on this issue and provides insights on additional education and resources that could help oncologists to provide much-needed support to patients."

Learn more.

Related Videos
Will Shapiro
Dr Padma Sripada, Columbia Internal Medicine
Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center
Joshua K. Sabari, MD< NYU Langone Perlmutter Cancer Center
dr marisa mcginley
Mila Felder, MD, FACEP
Leslie Busby, MD, Rocky Mountain Cancer Centers
Camilla Levister
dr daniel ontaneda
Sudipto Mukherjee, MD, PhD, MPH, hematology and medical oncology, Cleveland Clinic
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.